Sources indicate that the targeted premises include the residences of senior officials within the Tamil Nadu drug control department. This significant move follows a recent breakthrough in the Madhya Pradesh cough syrup tragedy, where at least 22 children in the Chhindwara district lost their lives after consuming ‘Coldrif’ branded cough syrup. This is the third major action by the ED against pharmaceutical companies in Chennai recently, highlighting a broader crackdown on illicit practices within the industry. Previously, in September, raids were conducted on premises linked to Arvind Remedies Ltd. concerning a ₹637 crore bank loan fraud, and in April 2024, 30 locations were searched in connection with a large-scale drug trafficking and money laundering operation. The investigation into Sreesan Pharma aims to uncover financial irregularities and potential money laundering activities linked to the production and distribution of the contaminated syrup. Authorities are determined to bring those responsible for this public health disaster to justice.

Previously, samples were sent to cities like Kolkata for quality checks. Now, Bihar will no longer need to rely on other states for these tests. The new facility will save time and enable timely action.

The laboratory houses 28 modern pieces of equipment, enabling micro-level examination of drugs and food items. This facility will make the state self-reliant in the health sector, technologically advancing the health department.

Health Minister Mangal Pandey stated that this laboratory ensures health security for Bihar’s 13 crore people, guaranteeing access to quality medicines. This initiative will reinforce the public’s right to health and supports the central government’s vision of a ‘Safe India, Healthy India.’ The inauguration was attended by Assembly Speaker Nand Kishore Yadav, Additional Chief Secretary of Health Pratyay Amrit, MD of BMSICL Divesh Ramchandra Devere, and other officials and leaders.